BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38243295)

  • 1. Potential role of RhoA GTPase regulation in type interferon signaling in systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Arthritis Res Ther; 2024 Jan; 26(1):31. PubMed ID: 38243295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RhoA GTPase regulates Type I Interferon Signaling in Systemic lupus erythematosus.
    Fan W; Wei B; Chen X; Zhang Y; Xiao P; Li K; Zhang YQ; Huang J; Leng L; Bucala R
    Res Sq; 2023 Sep; ():. PubMed ID: 37790522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE.
    Rozo C; Chinenov Y; Maharaj RK; Gupta S; Leuenberger L; Kirou KA; Bykerk VP; Goodman SM; Salmon JE; Pernis AB
    Ann Rheum Dis; 2017 Apr; 76(4):740-747. PubMed ID: 28283529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
    Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity.
    Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y
    Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
    Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
    Front Immunol; 2022; 13():962393. PubMed ID: 35967341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UXT attenuates the CGAS-STING1 signaling by targeting STING1 for autophagic degradation.
    Pan M; Yin Y; Hu T; Wang X; Jia T; Sun J; Wang Q; Meng W; Zhu J; Dai C; Hu H; Wang C
    Autophagy; 2023 Feb; 19(2):440-456. PubMed ID: 35543189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I Interferon Inhibition of MicroRNA-146a Maturation Through Up-Regulation of Monocyte Chemotactic Protein-Induced Protein 1 in Systemic Lupus Erythematosus.
    Qu B; Cao J; Zhang F; Cui H; Teng J; Li J; Liu Z; Morehouse C; Jallal B; Tang Y; Guo Q; Yao Y; Shen N
    Arthritis Rheumatol; 2015 Dec; 67(12):3209-18. PubMed ID: 26315540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.
    Ramírez-Vélez G; Medina F; Ramírez-Montaño L; Zarazúa-Lozada A; Hernández R; Llorente L; Moreno J
    PLoS One; 2012; 7(7):e41414. PubMed ID: 22859983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus.
    Enocsson H; Wetterö J; Eloranta ML; Gullstrand B; Svanberg C; Larsson M; Bengtsson AA; Rönnblom L; Sjöwall C
    Front Immunol; 2021; 12():688753. PubMed ID: 34276678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities of the type I interferon signaling pathway in lupus autoimmunity.
    Gallucci S; Meka S; Gamero AM
    Cytokine; 2021 Oct; 146():155633. PubMed ID: 34340046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
    Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
    PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte surface expression of Fcgamma receptor RI (CD64), a biomarker reflecting type-I interferon levels in systemic lupus erythematosus.
    Li Y; Lee PY; Kellner ES; Paulus M; Switanek J; Xu Y; Zhuang H; Sobel ES; Segal MS; Satoh M; Reeves WH
    Arthritis Res Ther; 2010; 12(3):R90. PubMed ID: 20478071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.
    Tang Y; Luo X; Cui H; Ni X; Yuan M; Guo Y; Huang X; Zhou H; de Vries N; Tak PP; Chen S; Shen N
    Arthritis Rheum; 2009 Apr; 60(4):1065-75. PubMed ID: 19333922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
    Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice.
    Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N
    Front Immunol; 2021; 12():653989. PubMed ID: 33868295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.